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Abstract The effect of K-tocopherol (vitamin E) on gene
expression in rat vascular smooth muscle cells was studied by
the differential display technique. One gene out of about 1000
genes analyzed, identified as K-tropomyosin, showed an in-
creased transcription level caused by K-tocopherol treatment.
Northern and Western blot analysis revealed a time-dependent
transient up-regulation of the amount of mRNA (peak between
2 and 3 h) and protein (peak at 5 h) in K-tocopherol-treated cells.
No effect was observed in cells treated with L-tocopherol.
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1. Introduction
Atherosclerosis is the major cause of age-related disease and
death in the world [1]. An early event in the onset of the
disease is the migration of smooth muscle cells from the media
to the intima of the arterial wall where they proliferate fol-
lowed by their release of matrix components that leads to the
formation of lesions protruding into the lumen [2]. K-Toco-
pherol, an antioxidant vitamin, has been found to reduce the
risk of disease development [3^5]. In recent years, other modes
of action of K-tocopherol have been demonstrated that cannot
be ascribed to its antioxidant property.
K-Tocopherol has been shown to inhibit vascular smooth
muscle cell proliferation through a non-antioxidant e¡ect via
protein kinase C [6,7]. Tocopherol binding proteins have been
found and identi¢ed in various tissues [8^10]. A function has
so far only been ascribed to the K-tocopherol transfer protein
found in liver cells, where it speci¢cally transfers K-tocopherol
to lipoprotein, thus regulating tocopherol levels in the body
[11]. The role of the other proteins is obscure, but it is hy-
pothesized that they might be responsible for a tissue speci¢c
cellular regulation of tocopherol transport. The only report
showing an e¡ect of K-tocopherol on the mRNA modulation
is that of an increased transcription of the gene of the K-
tocopherol binding protein in rat liver [12]. No systematic
study has been carried out, however, especially in view of
the inhibition by K-tocopherol of protein kinase C activity,
to establish if such an e¡ect could be in£uenced by transcrip-
tion factors with consequent transcription modulation.
In order to address the question, whether the expression of
some genes is modulated by K-tocopherol in rat vascular
smooth muscle cells, we chose the method of mRNA di¡er-
ential display [13]. In this report we show that K-tocopherol
treatment of serum stimulated cells leads to a transient in-
crease in K-tropomyosin mRNA and protein expression.
2. Material and methods
2.1. Materials
Tissue culture materials were purchased from Falcon Labware (Bec-
ton Dickinson AG, Basel, Switzerland) and Gibco Laboratories
(Grand Island, NY, USA). Growth media and serum for cell cultures
were obtained from Gibco Laboratories. Rat vascular smooth muscle
cells (A7r5) were purchased from the American Type Culture Collec-
tion (Rockville, MD, USA). RRR-K- and RRR-L-tocopherol were
generous gifts from Henkel Corporation (La Grange, USA). Actino-
mycin D was purchased from Sigma (St. Louis, MO, USA).
[35S]methionine, [K-32P]dATP, [K-35S]dATP and the enhanced chem-
iluminescence Western blotting analysis system were purchased from
Amersham International.
2.2. Cell culture
A7r5 cells were grown to con£uence in DMEM 10% fetal calf
serum (FCS). They were made quiescent for 48 h by incubation in
low serum media (DMEM/0.2% FCS). During the last 24 h, 50 WM
K-/L-tocopherol was added in ethanol solution (¢nal ethanol concen-
tration 0.1%) or ethanol alone was added to control cells.
Cells were then stimulated with DMEM/10% FCS in the presence
of 50 WM K- or L-tocopherol and harvested at the indicated times.
Cells were washed with cold PBS and used for RNA (using RNeasy
total RNA kit from Qiagen, Germany) or protein extraction. Actino-
mycin D was added at the beginning of the stimulation period, at a
concentration of 5 Wg/ml medium.
2.3. Di¡erential display
Di¡erential display [13] of total RNA was performed using two kits
from GenHunter Corporation (Nashville, TN, USA) according to the
manufacturers procedure.
Samples were analyzed on 6% polyacrylamide sequencing gels. Gels
were brie£y washed with distilled water, dried and exposed in a Bio-
Rad GS-250 Molecular Imager for 18 h.
2.4. Cloning and sequencing of cDNA fragments
Di¡erentially expressed cDNA fragments were re-ampli¢ed as de-
scribed by [13]. Following this, they were cloned into the pGEM-T
vector (Promega, Madison, WI, USA). Plasmid DNA sequencing was
carried out at the Department of Clinical Research of the University
of Bern. Sequence analysis was done using the Wisconsin Sequence
Analysis Package (Version 8) from GCG (Madison, WI, USA).
2.5. Northern blot analysis
Equal amounts of total RNA (10 Wg) were size-fractionated on a
1% (w/v) agarose gel in 20 mM MOPS, 5 mM Na-acetate, 0.5 mM
EDTA, pH 7.0, containing 2 M (6%) formaldehyde. RNA was trans-
ferred to a Zeta-Probe membrane (Bio-Rad Laboratories) using
10USSC (SSC: 0.15 M NaCl, 0.015 M sodium citrate, pH 7.0) and
cross-linked to the membrane using UV irradiation. The cDNA frag-
ments recovered from the di¡erential display analyses by re-ampli¢-
cation with the originally used primer pair and a fragment of the
encoding region of rat glyceraldehyde-3-phosphate dehydrogenase
(GAPDH, loading control) were labelled with [K-32P]dATP using
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the random prime labelling kit (Boehringer, Mannheim). Unincorpo-
rated label was removed using NICK spin columns (Pharmacia Bio-
tech). Pre-hybridization (10 min) and hybridization (overnight) was
performed at 42‡C in 50% formamide, 0.25 M NaCl, 0.12 M
NaH2PO4, pH 7.2, 1 mM EDTA, 7% SDS and 1U106 cpm/ml of
heat-denatured [K-32P]dATP-labelled cDNA probe. Blots were washed
in 1USSC/0.1% SDS at 42‡C, then in 0.25USSC/0.1% SDS at 42‡C,
48‡C, 54‡C and 60‡C for 20 min. Blots were exposed in a Bio-Rad
GS-250 Molecular Imager for 48 h, signals quanti¢ed with the Mo-
lecular Analyst software from Bio-Rad and normalized to the
GAPDH signals.
2.6. Western blot analysis
Cells were harvested by scraping and resuspended in a small volume
of ice cold disruption bu¡er (Tris-Cl 20 mM, EDTA 5 mM, EGTA
5 mM, pH 7.4) containing protease inhibitors and 1% Triton X-100.
Following disruption using a syringe G25, samples were centrifuged
(10 000Ug, 15 min, 4‡C) and supernatants stored at 370‡C until
analysis. The protein content was determined using the method of
Bradford [14]. Proteins (5^10 Wg per lane) were separated using a
10% SDS-PAGE separating gel ([20]) and electro-blotted onto a Im-
mobilon-P (Millipore, Bedford, MA, USA) membrane. K-Tropomyo-
sin protein was detected with a polyclonal rabbit anti-chicken gizzard
K-tropomyosin primary antibody (dilution 1:1000) from Sigma (St.
Louis, MO, USA) and visualized by chemiluminescence (ECL, Amer-
sham, Zuºrich, Switzerland) following labelling with horseradish per-
oxidase-labelled anti-rabbit IgG (dilution 1:10 000) (Amersham,
Zuºrich, Switzerland). Rabbit anti-mouse actin antibody was used as
primary antibody to control protein loading in addition to the protein
quantitation determination. Signals were quanti¢ed densitometrically
on a Bio-Rad GS-700 imaging densitometer.
2.7. Pulse-chase experiment
The culture medium was changed 75 min before harvesting of the
cells with methionine-free medium. 15 min before harvesting, the cells
were pulsed with [35S]methionine. The pulse time was during the last
15 min before harvesting.
Proteins were extracted, quanti¢ed and immunoprecipitated using
polyclonal K-tropomyosin antibodies according to the method de-
scribed by Eldering et al. [15]. The same volumes of samples were
loaded on a 10% SDS polyacrylamide gel, treated with Na-salicylate
(15%), dried and exposed to Fuji RX X-ray ¢lm at 370‡C for 20
days. Signals were quanti¢ed using a Bio-Rad GS-700 imaging densi-
tometer.
3. Results and discussion
About 1000 transcripts were analyzed by di¡erential display
using 20 di¡erent arbitrary primer combinations. Only one
band using the primer pair H-AP4 and oligo-dT primer H-
T11A of the GenHunter kit was reproducibly, di¡erentially
displayed (shown in Fig. 1A). DNA sequence analysis and
comparison with the gene databank showed that the fragment
was identical to a portion of the K-tropomyosin cDNA.
Northern blot analysis (Fig. 1B) showed a signi¢cant increase
for the K-tropomyosin mRNA expression of 1.6-fold for the
tocopherol-treated cells compared to control after 3 h stimu-
lation. In the presence of Actinomycin D, K-tocopherol-medi-
ated mRNA induction was completely prevented and the
mRNA level was identical to the tocopherol non-treated cells
(Fig. 1B). This indicates that tocopherol treatment leads to de
novo synthesis of tropomyosin mRNA and is not the result of
its increased degradation rate relative to control cells.
The time course of mRNA and protein expression is shown
in Fig. 2. mRNA levels peaked around 2 h after stimulation
for K-tocopherol-treated cells when normalized to control cells
reaching control levels after 7 h (Fig. 2A). Considering the
result of Fig. 1B, the maximum mRNA synthesis rate was in a
window between 2 and 3 h.
We asked the question whether the change in RNA expres-
sion would correspond to a change in the protein level. In
fact, it has been shown that heterozygous knockout mice for
the K-tropomyosin gene, although having a 50% reduction in
the mRNA level, exhibit a normal protein amount [16]. The
K-tropomyosin protein level showed a transient maximum 5 h
after stimulation in the presence of K-tocopherol returning to
the control levels after 7 h. This indicates that the smooth
muscle cells, as found in the knockout mice, tend to maintain
a constant steady state concentration of tropomyosin protein
(Fig. 2A). No signi¢cant changes for mRNA and protein
levels were observed when L-tocopherol (a related derivative
of K-tocopherol) was used (Fig. 2B) indicating a di¡erent
mode of action for the two homologues.
In a next step, we analyzed the time course of tropomyosin
synthesis rate by pulse-chase labelling experiments. The high-
est protein synthesis rate was observed in the 5 h window
where also the highest accumulated protein levels (see Fig.
3A) were observed. Since the maximum protein accumulation
and highest protein synthesis rate coincide (between 4 and 5 h
after stimulation), it has to be assumed that an increased
protein degradation occurs in the window between 5 and 7 h
in order to reach the level of control cells after 7 h.
There is general agreement in support of the mechanism by
which tropomyosin sterically prevents actin-myosin interac-
tions [17]. Both in vitro and in vivo evidence suggest that
multiple isoforms of tropomyosin in non-muscle cells may
be required for regulating the actin ¢lament stability, intra-
cellular granule movement, cell shape determination and cy-
tokinesis. Tropomyosin binding proteins such as caldesmon,
tropomodulin and other unidenti¢ed proteins may be required
for some of these functions [18]. The role of tropomyosin is
especially important in vascular smooth muscle cells, where
the force generated between thin and thick ¢laments provides
the mechanism for cell shortening and in£uences the arterial
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Fig. 1. Di¡erential display and Northern blot analysis of K-tropo-
myosin gene expression in K-tocopherol-treated A7r5 smooth muscle
cells. (A) Autoradiography obtained from mRNA di¡erential dis-
play of synchronized cells following re-stimulation with 10% FCS in
the presence of 50 WM K-tocopherol for 3 h at 37‡C/5% CO2. The
arrow indicates the mRNA present in an increased amount in toco-
pherol-treated cells compared to controls. (B) Northern blot analysis
of tropomyosin mRNA expression after 3 h treatment. 15 Wg of to-
tal RNA was loaded for each lane and hybridized with the re-ampli-
¢ed and sub-cloned 32P-labelled tropomyosin fragment recovered
from the di¡erential display gel marked with the arrow in (A).
GAPDH was used as loading control.
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blood pressure [19]. On the other side, results have been re-
ported suggesting that hypertensive patients may have an in-
creased lipid peroxidation and reduced protection from vita-
mins C and E [20]. It has also been shown that short term oral
high dose combination antioxidant therapy reduces the blood
pressure [21]. An involvement of tropomyosin in the progres-
sion of atherosclerosis has also been suggested. Early after
balloon injury, smooth muscle cells of the media and those
that have migrated into the intima contain decreased amounts
of tropomyosin and late after balloon injury tropomyosin
returns toward normal values [22]. The overexpression of tro-
pomyosin in smooth muscle cells, induced by K-tocopherol
described in this study, may thus be relevant in understanding,
at a molecular basis, the diminution of the blood pressure
induced by antioxidants such as vitamin E. Such an event
may be the consequence of a lesser contractility of smooth
muscle cells containing more tropomyosin.
Furthermore, changes of tropomyosin isoforms have previ-
ously been found accompanying morphologic alterations such
as those associated with neoplastic transformations in mam-
malian cells [23]. TGF-alpha initiates the disassembly of cy-
toskeletal stress ¢bers and suppresses the synthesis of tropo-
myosin isoforms and stimulates their degradation [24]. The
induced expression of tropomyosin by K-tocopherol may be
in part at the basis of an anti-neoplastic e¡ect of K-tocopherol
It has been shown that PKCs are involved in remodelling of
the actin cytoskeleton, partly by phosphorylating speci¢c
PKC substrates such as the MARCKS protein and pleckstrin
[25,26]. A direct connection between the PKC activity and
cytoskeleton modelling therefore exists. Since K-tocopherol
is known to have an inhibitory e¡ect on smooth muscle cell
proliferation via inhibition of PKC activity, it might be pos-
sible that the observed tropomyosin expression is one of the
signals indirectly elicited on the cytoskeleton via a reduced
PKC activity. On the other hand, it might be possible that
signalling pathways independent of PKC activity exist, which
are triggered by K-tocopherol, leading to the observed transi-
ent modulation of tropomyosin expression. The molecular
events involved in this response are the object of current in-
vestigation.
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signals obtained for the tocopherol treated cells were normalized to
control cells.
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treatment with K- (Fig. 2A) and L-tocopherol (Fig. 2B). Cells were
harvested at the indicated times after treatment with tocopherol.
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sents the result of one out of three independent experiments.
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